Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma

Clinical trial NCT00669877 · COMPLETED

Trial details

NCT number: NCT00669877
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Burkitt's Lymphoma Burkitt'S-like Lymphoma

Start date: 2002-08-01
Primary completion: 2015-10-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.